Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Glutamine-induced recovery in intestinal barrier function by reducing bacterial translocation
was demonstrated in previous studies. In this trial, intensive care unit patients with
enteral feeding will receive either enteral glutamine or maltodextrin as placebo for 10 days
and the effects of the intervention on intestinal permeability will be assessed.